Distribution and drug resistance of Pseudomonas aeruginosa in a military hospital

WANG Nan; ZHANG Cui; and XUE Jing

PDF(591 KB)

Medical Journal of the Chinese People Armed Police Forces ›› 2019, Vol. 30 ›› Issue (8) : 690-692.

Distribution and drug resistance of Pseudomonas aeruginosa in a military hospital

WANG Nan¹, ZHANG Cui², and XUE Jing¹

Author information +

History +

Abstract

Objective To investigate the clinical distribution and drug resistance of Pseudomonas aeruginosa in order to provide evidence and reference for clinical prevention and treatment.Methods Strains of Pseudomonas aeruginosa were isolated and tested for sensitivity in 2018.Results A total of 160 clinical isolates were collected. The main source of the samples was sputum, which accounted for 81.88%. Pseudomonas aeruginosa infections mainly occurred in the Department of Neurosurgery (53 strains), ICU (48 strains) and Department of Respiratory Disease (13 strains). The 160 strains of pseudomonas aeruginosa were mostly susceptible to polymyxin B (susceptible rate 95.0%), but resistant to ticarcillin/clavulanic acid (resistance rate 51.2%).Conclusions Pseudomonas aeruginosa is susceptible to polymyxin B, cefoperazone/sulbactam and amikacin. Drug resistance of Pseudomonas aeruginosa should be monitored in order to select the right antibiotics in clinic.

Key words

Pseudomonas aeruginosa / clinical distribution / drug resistance / carbapenem / polymyxin B

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

WANG Nan, ZHANG Cui, and XUE Jing. Distribution and drug resistance of Pseudomonas aeruginosa in a military hospital[J]. Medical Journal of the Chinese People Armed Police Forces. 2019, 30(8): 690-692

References

[1] 中华医学会呼吸病学分会感染学组. 铜绿假单胞菌下呼吸道感染诊治专家共识[J].中华结核和呼吸杂志, 2014,37(1):9-15.
[2] 王延茹, 张智琪, 高雅婷,等. 喹诺酮信号分子和环丙沙星诱导铜绿假单胞菌对环丙沙星最低抑菌浓度影响的比较[J].中国临床药理学杂志, 2018,34(9):1115-1118.
[3] 李蓓,骆文玲,解晓悦,等. 2012-2016年本医院内获得性肺炎病原菌分布及革兰阴性杆菌耐药性分析[J].武警医学,2017,28(11):1151-1154.
[4] Goncalves C F, Silva A R, Burth P, et al. Possible mechanisms of pseudomonas aeruginosa -associated lung disease [J].Int J Med Microbiol, 2016,306(1)20-28.
[5] 李绪定. 碳青霉稀类治疗铜绿假单胞菌肺炎的临床效果分析[J].医学信息, 2018,31(13):134-136.
[6] Buhl M, Peter S, Willmann M. Prevalence and risk factors associated with colonization and infection of extensively drug resistant Pseudomonas aeruginosa: a systematic review [J].Expert Rev Anti Infect Ther, 2015, 13(9):1159-1170.
[7] Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing standards[S]. M100-S23, CLSI, 2015.
[8] 胡付品, 郭燕, 朱德妹, 等. 2017 年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志,2018,18(3):241-251.
[9] 周燕飞, 庞艳, 王斌. 铜绿假单胞菌感染临床分布及耐药性分析[J].中华医院感染学杂志,2014,24(17):4177 -4178.
[10] 黄勋, 邓子德, 倪语星, 等. 多重耐药细菌医院感染预防与控制中国专家共识 [J].中国感染控制杂志,2015, 14(1):1-9.
[11] Magiorakos A P, Srinivasan A, Carey R B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance[J]. Clin Microbiol Infect, 2012,18(3):268-281.
[12] 蒋逸, 沈佳丽, 蒋文玥, 等.34株耐亚胺培南铜绿假单胞菌的药物敏感分析及耐药机制探讨[J].智慧健康,2018, 4(19):19-20.
[13] Nakajima A, Sugimoto Y, Yoneyama H, et al. High-level fluoroquilone resistance in Pseudomonas aeruginosa due to interplay of the MexAB-OprM efflux pump and the DNA gyrase mutation[J]. Med Microbiol Immuno,2002,46(6): 391-395.
[14] 袁瑾懿, 余慧, 郭燕, 等.广泛耐药铜绿假单胞菌甲基化酶基因的检测和基因周边结构分析[J].中国感染与化疗杂志,2018,18(3):273-277
[15] 王芊, 华川.铜绿假单胞菌对碳青霉烯类抗菌药物耐药现状研究进展[J].解放军医学杂志,2013,25(7):87-89.
[16] Falagas M E, Rafailidis P I, Matthaiou D K. Resistance to polymyxins: mechanisms, frequency and treatment options [J]. Drug Resist Updat, 2013, 13(4-5)132-138.